Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis
Clinical trial NCT04984278 · TERMINATED
Trial details
- NCT number
- NCT04984278
- Sponsor
- Jazz Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-16
- Primary completion
- 2022-11-11
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.